Challenges assessing clinical endpoints in early Huntington disease

The primary aim of this study was to evaluate the current accepted standard clinical endpoint for the earliest-studied HD participants likely to be recruited into clinical trials. Since the advent of genetic testing for HD, it is possible to identify gene carriers prior to the diagnosis of disease,...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Paulsen, Jane S., Wang, Chiachi, Duff, Kevin, Barker, Roger, Nance, Martha, Beglinger, Leigh, Moser, David, Williams, Janet K., Simpson, Sheila, Langbehn, Douglas, van Kammen, Daniel P.
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2978744/
https://ncbi.nlm.nih.gov/pubmed/20623772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.23337
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы